Article info

Download PDFPDF

p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification

Authors

  1. Correspondence to Dr Jessica N McAlpine, Department of Gynecology and Obstetrics, Division Gynecologic Oncology, University of British Columbia, Vancouver, BC V5Z1M7, Canada; jessica.mcalpine{at}vch.ca
View Full Text

Citation

Jamieson A, Thompson EF, Huvila J, et al
p53abn Endometrial Cancer: understanding the most aggressive endometrial cancers in the era of molecular classification

Publication history

  • Received November 16, 2020
  • Revision received January 20, 2021
  • Accepted January 28, 2021
  • First published February 15, 2021.
Online issue publication 
June 07, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.